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Abstract.  Radioiodinated ubiquitin was introduced 
into HeLa cells by erythrocyte-mediated microinjec- 
tion.  Subsequent electrophoretic analyses revealed that 
the injected ubiquitin molecules were rapidly con- 
jugated to HeLa proteins. At equilibrium,  10%  of the 
injected ubiquitin was conjugated to histones and 40% 
was distributed among conjugates of higher molecular 
weight. Although the remaining ubiquitin molecules 
appeared to be unconjugated, the free pool of ubiqui- 
tin decreased by one-third and additional conjugates 
were present when electrophoresis was performed at 
low temperature under nonreducing conditions. Molec- 
ular weights of these labile conjugates suggest that 
they are ubiquitin adducts in thiolester linkage to ac- 
tivating enzymes. Despite the fairly rapid degradation 
of injected ubiquitin (t,~ 'x,10-20 h), the size distribu- 
tion of ubiquitin conjugates within interphase HeLa 
cells remained constant for at least 24 h after in- 
jection. 
The intracellular locations of ubiquitin and ubiquitin 
conjugates were determined by autoradiography, by 
differential sedimentation of subcellular fractions in 
sucrose, and by extraction of injected cells with buffer 
containing Triton X-100. Free ubiquitin was found 
mostly in the cytosolic or Triton X-100-soluble frac- 
tions. As expected, histone conjugates were located 
predominately in the nuclear fraction and exclusively 
in the Triton X-100-insoluble fraction. Although high 
molecular weight conjugates were enriched in the Tri- 
ton X-100-insoluble fraction, their size distribution 
was similar to that of soluble conjugates. 
When injected HeLa cells were exposed to cyclohex- 
irnide to inhibit protein synthesis, the size distribution 
of ubiquitin conjugates was similar to that found in 
untreated cells. Moreover, high molecular weight con- 
jugates decreased <20%  after inhibition of protein 
synthesis. These results indicate that most ubiquitin 
conjugates are not newly synthesized proteins which 
have been marked for destruction. 
U 
'BIQU1TIN is an 8,500-mol-wt, heat-stable polypeptide 
found in all eukaryotic cells (19). It has been se- 
quenced from a variety of organisms (5, 12, 44, 54, 
57) and comparison of yeast to human ubiquitin reveals only 
three amino acid substitutions in the 76 residues that com- 
prise the protein. Such a high degree of evolutionary conser- 
vation implies an important physiological role for ubiquitin. 
The molecule is known to be necessary for ATP-dependent 
proteolysis in reticulocyte lysates (11, 25),  where its ability 
to form covalent conjugates to other proteins is essential for 
this activity (58). During the conjugation reaction, the car- 
boxyl terminus of ubiquitin  forms an isopeptide  linkage to 
e-amino groups of lysine residues in the ubiquitinated pro- 
teins (26). 
Hershko et al. (26) proposed that the covalent attachment 
of ubiquitin to proteins converts them to substrates for pro- 
teolytic enzymes. This hypothesis  has received increasing 
support during the past five years (for review see reference 
14). First,  hemoglobin injected  into  cultured mammalian 
cells  and subsequently  denatured with phenylhydrazine  is 
rapidly degraded (24),  and  the concentration of globin- 
ubiquitin conjugates that form upon denaturation is propor- 
tional to the rate of globin degradation (8). Second, proteins 
that  incorporate  amino acid analogs  are  usually rapidly 
degraded (2, 18). When Ehrlich ascites cells are exposed to 
amino acid analogs, there is an increase in the intracellular 
concentration of ubiquitin conjugates (27). Third, the mouse 
cell  line  ts85  contains  a  heat-labile  ubiquitin  activating 
enzyme, Ez  (15), and the ability of these cells to degrade 
short-lived proteins at nonpermissive temperatures is mark- 
edly impaired  (10). Fourth,  Dictyostelium calmodulin is 
ubiquitinated  at  lysine  115  and subsequently  degraded in 
reticulocyte lysates; bovine calmodulin is methylated at ly- 
sine 115, does not conjugate to ubiquitin, and is more stable 
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direct support by the recent demonstration that reticulocyte 
lysates  contain  a  large,  ATP-dependent  protease  that  de- 
grades lysozyme molecules conjugated to ubiquitin, but does 
not degrade free lysozyme (29, 30). 
Proteolysis may not be the only function for ubiquitin.  A 
sizable proportion of the histone H2A and H2B pool is ubi- 
quitinated to form uH2A and uH2B in interphase ceils (41, 
55, 56). Since H2A and H2B are stable proteins (60), attach- 
ment of ubiquitin to a protein does not necessarily lead to the 
latter's destruction. Rather, ubiquitinated histones may affect 
transcription as suggested by their enrichment in the HSP 70 
gene of Drosophila  (35). It has been reported that uH2A and 
uH2B decrease in metaphase cells and reappear at anaphase 
(37, 41,  60).  This  transient  disappearance  may  influence 
chromatin condensation  (37) or cell cycle progression (61), 
or may serve to protect histones against proteolysis upon dis- 
solution of the nuclear envelope (8). 
Increased knowledge of the intracellular  location,  stabil- 
ity, and molecular weight distribution of ubiquitin conjugates 
should contribute to an eventual understanding  of the roles 
of this highly conserved protein. Injection of radioiodinated 
ubiquitin  into cultured  cells is ideal  for such an analysis. 
Since ubiquitin  is the only labeled protein  in the injected 
cells, formation of conjugates can readily be detected by SDS 
PAGE and autoradiography.  Moreover, unlike immunologi- 
cal methods, conjugate detection does not depend on ubiqui- 
tin conformation. We report here on the behavior of ubiquitin 
injected into HeLa cells grown under normal culture condi- 
tions.  In the  following paper (6),  we describe changes in 
ubiquitin metabolism after heat-shock. 
Materials and Methods 
Purification of Ubiquitin 
Human ubiqultin was isolated from red blood cells (RBCs) l by a modifica- 
tion of the procedure of Wilkinson and Audhya (58).  Briefly,  900 mi of 
packed RBCs were added slowly to 2,700 ml of water preheated to 85-90°C 
to heat-precipitate contaminating proteins. This solution was then filtered 
through Whatman No.  1 paper,  mI-ubiquitin was added as a tracer, and 
contaminating proteins were precipitated with 40%  saturated ammonium 
sulfate. At~r centrifugation at 9,200 g for 25 min, the supernate was taken 
to 85% saturation in ammonium sulfate, centrifuged as above, and the pro- 
tein precipitate was dissolved in 70 ml of 10 mM sodium phosphate, 20 mM 
potassium chloride, pH 7.0. The sample was dialyzed against three l-liter 
changes of the same buffer before chromatography on a 30-mi column of 
DE-52 cellulose. 
Peak ubiquitin fractions, located from the position of the added  tzsI- 
ubiquitin, were pooled and adsorbed to a 170-ml hydroxyapatite column pre- 
equilibrated with 5 mM sodium phosphate, pH 6.8. Ul",iquitin was eluted at 
50 mM sodium phosphate, pH 6.8, and then dialyzed against water before 
lyophilization. The lyophilized sample was dissolved in 7 ml of 0.1 M am- 
monium carbonate and chromatographed on a  2.5  ×  20  cm column of 
Sephadex G-50 at 4°C. The peak fractions were pooled, dialyzed against 
10  mM  potassium phosphate,  pH  6.0, absorbed onto  a  30-ml  CM-52 
column, and elul~l with a 25-125 mM potassium chloride gradient. The 
~SI-ubiqultin,  which eluted at 36 mM potassium chloride, was dialyzed 
against three l-liter changes of water, lyophilized, and stored dessicated at 
4°C. 
SDS PAGE analysis after radiolabeling demonstrated that the isolated 
ubiquitin co-migrated with a known ubiquitin standard and was >95 % pure. 
HPLC analysis confirmed that >95 % of the isolated ubiquitin eluted as a 
single peak (Smith, S., and W. Gray, unpublished observation). 
1. Abbreviations used in this paper: BH-ubiquitin, ubiquitin labeled accord- 
ing to the Bolton-Hunter procedure; CT-ubiquitin, chloramine-T-labeled 
ubiquitin; HMW, high molecular weight; RBC, red blood cell. 
Radiolabeling of Ubiquitin 
Ubiquitin was radiolabeled by one of three methods: reductive methylation 
with tritiated sodium borohydride as described by Tack et al. (53), radioio- 
dination by the chloramine-T method (CT-ubiquitin)  as described previously 
(8), or by a modification of the Bolton and Hunter procedure (4). In the lat- 
ter method, 2.0 Ixl of  a 1.7 medml solution of Bolton-Hunter reagent in diox- 
ane was mixed with 2 mCi (20  ltl) of NamI in the presence of 10 Itl of 
chloramine-T at 1 mg/ml in 0.15 M sodium phosphate buffer, pH 7.5. The 
reaction was quickly terminated by addition of 5 gl of a 2-mg/ml solution 
of sodium meta-bisulfite in 0.15 M sodium phosphate, pH 7.5. The radioiodi- 
hated Bolton-Hunter reagent was then coupled to ubiqultin by addition of 
10 ltl of a 3.5 mg/ml solution of uhiqultin in 0.15 M sodium borate, pH 8.5. 
After 30 min, the labeled ubiqultin (BH-ubiquitin) was separated from un- 
reacted iodine and iodinated Bolton-Hunter reagent by passage through a 
3-ml column of Sephadex G-25  equilibrated with  10 mM Tris,  pH 7.5. 
Specific activities ranged from 10-20 I.tCi/gg for BH-ubiquitin and 0.5 to 
0.9 taCi/l.tg for CT-ubiquitin. 
3 tool of Bolton-Hunter reagent were added for each ubiquitin molecule, 
and typical incorporation of nsI was '°33%, or "01 BoRon-Hunter group 
per molecule of ubiqultin. Because the incorporation of each 3(4-hydroxy- 
phenyl) propionamide group removes one positive charge from the protein, 
several isoelectric forms of ubiqultin were observed by both acid-urea and 
two-dimensional gel analysis (6). 
CT-ubiquitin is reported to stimulate ATP-dependent proteolysis differ- 
ently than native ubiqultin (59). However, the intraceUular stability of ubiq- 
uitin (see Fig.  1) and the molecular weight distribution of ubiquitin con- 
jugates were similar after injection of either CT- or BH-ubiquitin (data not 
shown). Because of its 10-fold higher specific activity,  BH-ubiquitin was 
used for most experiments. 
Cell Culture and RBC-mediated Microinjection 
HeLa ceils were maintained at 37°C in Ham's F-12 media (23) supplemented 
with 100 U/nil of penicillin, streptomycin, and 5 % calf serum. Radiolabeled 
ubiquitin was introduced into the cells by RBC-mediated microinjection as 
described previously (51). Typically 30% of the labeled ubiquitin was re- 
tained in the RBC during loading, and 1.0% of the loaded BH-ubiquitin was 
transferred to the HeLa cells. 
Preparation of CeU Extracts  for Gel Electrophoresis 
Interphase cells were harvested with 0.1% trypsin in Mg++/Ca++-free sa- 
line, rinsed twice with cold PBS, and dissolved in 2x  SDS sample buffer 
(lx  SDS sample buffer =  0.4 M  13-mereaptoethanol,  10%  glycerol, 3% 
SDS, and 62.5 mM Tris, pH 6.8) (34). Metaphase cells, isolated by mitotic 
shake-off  24 h post-injection (13), were washed two times with ice-cold PBS 
before dissolving in SDS sample buffer.  All samples were stored frozen at 
-70°C before electrophoresis (34).  For analysis on nonreducing gels, cell 
pellets were first extracted for 30 min on ice with Triton X-100 extraction 
buffer (16) containing 100 ttg/ml DNase 1, then dissolved in 3 x  SDS sample 
buffer without 2-mercaptoethanol and immediately analyzed by SDS PAGE 
at 4°C. Samples for acid-urea gel analyses were prepared by extracting fro- 
zen cell pellets with 0.2 M  sulfuric acid. 
Cell Fractionation 
Cell fractionations were performed by differential sedimentation in sucrose 
as described (3), or by extraction of  ceUs with buffer containing 0.5 % Triton 
X-100 (16) and 5  mM N-ethylmaleimide to inhibit isopeptidase activity. 
Cells were removed from the monolayer by trypsinization in 0.25 M  su- 
crose, 1 mM EDTA, and disrupted in a Dounce homogenizer (65 strokes); 
cell breakage was >90%.  Nuclear pellets were obtained by centrifugation 
at 2,000 g for 10 min. Cells extracted with Triton X-100 were centrifuged 
for 10 rain at 15,600 g in an Eppendorf microcentrifuge to produce particu- 
late and soluble fractions. Fractions analyzed by SDS PAGE were dissolved 
in 2 x  SDS sample buffer or were mixed with equal volumes of 4 x  SDS 
sample buffer and frozen at  -70°C. 
Autoradiography 
HeLa cells injected with BH-ubiquitin were fixed in Karnovsky's solution 
(32), dehydrated in ethanol, embedded in Medcast plastic resin, and pre- 
pared for autoradiography as described previously (40). 
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jected  into  HeLa  cells.  (a) 
Molecular weight distribution 
of  uSI-ubiquitin  in  injected 
cells.  HeLa cells were  fused 
with  ubiquitin-loaded  RBCs 
and  samples  obtained  from 
the  injected cells  (either im- 
mediately  after  fusion  [Fus. 
m/x] or at the various times in- 
dicated above each lane) were 
analyzed  by  electrophoresis 
on  10%  acrylamide gels.  (b) 
Molecular  weight  distribu- 
tion of teSI-ubiquitin  in loaded 
RBCs. RBCs were loaded with 
mI-ubiquitin  and incubated at 
37"C in culture medium. The 
fate of ubiquitin within RBCs 
was determined by SDS PAGE 
analysis and autoradiography 
for  samples  removed  at  the 
times shown. Each lane con- 
tained  20,000  cpm,  and  the 
gels were exposed  for 3.5 d. 
Lanes marked 0 and 24 h in b 
were  cut into 5-mm sections 
and the radioisotope  in each 
slice  was  quantitated;  free 
ubiquitin comprised  90  and 
80%, respectively, of the total 
cpm in these lanes. (c) Forma- 
tion of ubiquitin-histone  con- 
jugates  from  microinjected 
ubiquitin. HeLa cells were in- 
jected with  t25I-ubiquitin and 
samples taken at various times 
post-injection were  analyzed 
by  SDS  PAGE.  Gels  were 
sliced  into  5-mm  segments 
and the amount of t25I in the 
bands corresponding to uH2A 
and uH2B was determined by 
gamma spectroscopy. Because 
all of the injected HeLa cells 
did  not attach  to  the  culture 
dish within the first 2  h  after 
fusion,  unfused RBCs  could 
not  be  removed  by  rinsing. 
Corrections for RBC contami- 
nation  at  early  times  were 
made by lysing residual RBCs 
in 0.83%  NI-hC1  (31) or  by 
estimating the  contamination 
from the reduced rate of ubiq- 
uitin  degradation.  The  cor- 
rectexi  value is denoted by a 
dashed line. 
Polyacrylaraide Gel Electrophoresis 
Proteins were analyzed by SDS PAGE (10% acrylamide) (34) or acid-urea 
PAGE (45). Molecular weight standards, obtained from Sigma Chemical 
Co. (St. Louis, MO), consisted of rabbit myosin (205,000), ~galactosidase 
(116,000), rabbit phosphorylase  B (97,400), BSA (66,000), egg albumin 
(45,000), rabbit glyceraldehyde 3-phosphate dehydrogenase (36,000), bo- 
vine carbonic anhydrase (29,000), PMSF-treated trypsinogen (24,000), soy- 
bean trypsin inhibitor (20,100), and u-lactalbumin (14,200). Acid-extracted 
samples were brought to a final concentration of 8 M urea, 20 mM "Iris, 
and 7 % 2-mercaptoethanoi before being applied to acid urea gels. Standards 
for these gels were histones HI, H2A, H2B, H3, and H4 (a gift from L. Wu, 
University of Utah). 
Some gels were stained in 0.2%  Coomassie Brilliant Blue in 22.5% 
methanol, 7.5% acetic acid for 1 h, and subsequently destained in metha- 
nol/acetic acid alone. Gels were then dried onto Whatman 3MM paper 
(Whatman Inc., Clifton, NJ) and exposed at -70°C to either Kodak XAR 
or BB-1 X-ray film with DuPont Lightning plus intensifier screens. To pre- 
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tion in HeLa extracts. Extracts 
were  prepared  from  unin- 
jected HeLa cells (14) and in- 
cubated with  1.5  x  106 cpm 
of mI-ubiquitin in a final vol- 
ume of 100 I.tl. Labeled ubiq- 
uitin was either added to the 
extract directly from the iodi- 
nation  mixture  (HeLa ex- 
tract),  or  from  ubiquitin- 
loaded RBCs lysed directly in 
the extract (HeLa extract + 
RBCs). These  samples were 
incubated in the presence of 
an  ATP  regeneration  system 
(+A/P) or ATP depletion sys- 
tem (-ATP) as described (7). 
SDS PAGE analysis was con- 
ducted  on  samples  removed 
immediately after  mixing  (0 
time) or after a 20- or 60-rain 
incubation at 37°C. 
vent loss of mdiolabeled ubiquitin in experiments involving direct quantita- 
tion, unstained gels were dried onto Whatman 3 MM paper, and lanes were 
cut into 5-mm pieces.  Each slice was then counted in a  gamma counter 
(model 4000;  Beckman Instruments, Inc.,  Palo Alto, CA). 
Measurement of  Proteolysis 
The release of acid-soluble and acid-insoluble radioactivity from injected 
HeLa cells was measured as described (40).  Paper chromatography con- 
firmed that  >90%  of the released TCA-soluble radioactivity  was  iodo- 
tyrosine (CT-ubiquitin) or iodo-Bolton-Hunter lysine (BH-ubiquitin) (50). 
Rates of proteolysis were calculated by the method of McGarry et al. (40) 
or Neff et al.  (43). 
Materials 
Calf sera were obtained from Flow Laboratories, Inc.  (McLean, VA) or 
Sterile Systems, Inc. (Logan, UT); Ham's F-12 medium was obtained from 
Gibco (Santa Clara, CA). Radiochernicals were obtained from Amersham 
Corp. (Arlington Heights, IL). Bis-acrylamide was obtained from Eastman 
Kodak  Co.  (Rochester,  NY).  Acrylamide,  chloramine-T,  sodium meta- 
bisulfite, and ammonium  sulfate were from J. T. Baker Chemical Co. (Phil- 
lipsburg,  NJ).  BoRon-Hunter  reagent  was  obtained  from  Calbiochem- 
Behring Corp.  (San Diego, CA) under the commercial name of "Pagit. All 
other chemicals were obtained from Sigma Chemical Co. (St. Louis, MO). 
Results 
Ubiquitin Conjugation and Degradation in Injected 
HeLa Cells 
The fate of ubiquitin after injection into HeLa cells is shown 
in  the  electrophoretic pattern  presented  in  Fig.  1.  Imme- 
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Figure 3.  Degradation of injected ubiquitin. HeLa ceils were in- 
jected with ubiquitin labeled with t25I either by chloramine-T oxi- 
dation or by reaction with uSI-Bolton-Hunter reagent (see Materi- 
als and  Methods).  Release of acid-soluble mI into the medium 
was then determined, and rates of  proteolysis  were calculated  by the 
method of Neff et al. (43). (Solid circles) CT-ubiquitin; (open cir- 
cles) BH-ubiquitin. 
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weight conjugates (see lane labeled Fus. m/x, Fig.  1 a). Ex- 
cept  for the  slower appearance  of ubiquitinated  histones, 
there was little change in the size distribution of conjugates 
thereafter (Fig.  1 a, lanes 2.5-24  hours and Fig. 1 c). Small 
amounts  of  ubiquitin  conjugates  were  present  in  loaded 
RBCs before injection and incubation of loaded RBCs in cul- 
ture media for up to 24 h converted an additional 10% of the 
loaded ubiquitin to higher molecular weight forms (Fig. 1 b). 
These data and data demonstrating the remarkable stability 
of ubiquitin  in RBCs (t~ >  30 d) indicate that ubiquitin  is 
not altered in RBCs, but these results do not rule out the pos- 
sibility that  formation of ubiquitin  conjugates  in  recipient 
HeLa cells is due to components transferred from the RBCs. 
Earlier reports that ubiquitin introduced into HeLa cells by 
osmotic lysis of pinosomes was capable of forming conju- 
gates suggested that HeLa cells contain an intact conjugation 
pathway (8). This was confirmed by analysis of ubiquitin con- 
jugation  in vitro.  Extracts prepared from uninjected  HeLa 
cells were capable of conjugating ubiquitin to a variety of en- 
dogenous proteins, and addition ofRBC lysate to this extract 
contributed no additional  conjugating activity (Fig.  2). 
From pulse-chase experiments, Wu et al.  (60)  reported 
that native ubiquitin is lost from Chinese hamster ovary cells 
with a half-life of 9 h. In close agreement with their results, 
we observed that ubiquitin labeled by the chloramine-T pro- 
cedure, the Bolton-Hunter procedure, or reductive methyla- 
tion, and then injected into HeLa cells was lost from the cells 
with half-lives of 11, 13, or 16 h, respectively. Not all loss of 
ubiquitin was due to its degradation; some of the radiolabel 
was released in acid-insoluble form (data not shown).  The 
release of acid-soluble radiolabel from HeLa cells injected 
with either CT- or BH-labeled ubiquitin  (presented graphi- 
cally in Fig. 3) showed that the two molecules were degraded 
at equivalent rates (t,h <  20 h). 
Figure 4.  Distribution of 125I-ubiquitin and  12SI-ubiquitin conjugates in injected HeLa cells.  (,4) Size distribution of ubiquitin conjugates 
at interphase.  12 h after injection with  ~2SI-ubiquitin, HeLa cells were extracted in buffer containing 0.5% Triton X-100 or fractionated 
in 0.25 M sucrose (see Materials and Methods).  SDS PAGE followed by autoradiography was then used to determine the distribution of 
free ubiquitin and ubiquitin conjugates in Triton X-100-soluble and -insoluble fractions or in the postnuclear  supernate and the nuclear 
pellet.  Each lane contained  10,000 cpm; autoradiographic exposure was for 5 d.  (B) Size distribution  of ubiquitin conjugates in mitotic 
cells. HeLa cells were injected with 125I-ubiquitin, and 24 h later, colcemid was added to a final concentration of 0.1  lxg/ml. After 4 h, 
mitotic cells were isolated by shake-off and interphase cells were collected by trypsinization.  SDS PAGE analysis and autoradiography 
were performed.  Each lane contained 10,000 cpm and autoradiographic exposure was for 8 d. The mitotic index was >85 % for colcemid- 
arrested cells.  The arrow identifies a 26,000-mol-wt conjugate unique to mitotic cells. 
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Ubiquitin  Conjugates 
For convenience, we consider injected ubiquitin to be pres- 
ent in three metabolic compartments or pools: the free pool, 
histone conjugates, and high molecular weight (HMW) con- 
jugates.  From eight  independent measurements on inter- 
phase HeLa cells, the partitioning of ubiquitin among these 
three compartments was 42%  HMW conjugates,  10% his- 
tone conjugates, and 48% in the free pool; the standard devi- 
ation for all values was <3 %. 
Autoradiography on thin sections of HeLa cells injected 
with ubiquitin revealed similar grain densities over nucleus 
and cytoplasm. However,  autoradiography may not distin- 
guish between free and conjugated ubiquitin. To determine 
the subcellular distribution of components of the three meta- 
bolic pools, injected HeLa cells were extracted with buffer 
containing  Triton  X-100 or  fractionated  in  sucrose  (see 
Materials and Methods). The crude nuclear and cytosolic 
fractions were analyzed by SDS PAGE (Fig. 4 A) and the dis- 
tribution of ubiquitin among the various pools was deter- 
mined for each fraction (Table I). At 12 h post-injection, free 
ubiquitin was found mainly in the Triton X-100-soluble  or in 
the postnuclear supernate obtained after homogenization in 
sucrose. Ubiquitin-histone adducts were present exclusively 
in the Triton X-100-insoluble fraction and greatly enriched 
in nuclear pellets. Although HMW conjugates appeared in 
all  fractions,  several  differences in  their  size distribution 
were observed between Triton X-100-soluble  and -insoluble 
fractions (arrows in Fig. 4 A). Similar distributions of radio- 
label were found when cells were fractionated at 4 and 53 h 
post-fusion. 
To examine ubiquitin pools at mitosis, HeLa cells were in- 
jected with BH-ubiquitin and mitotic cells were isolated 24 h 
later.  Both  metaphase-arrested  cells  and  interphase  cells 
were analyzed by SDS PAGE (Fig. 4 B) or acid-urea PAGE 
(not shown), and in three experiments, we consistently ob- 
served the following differences: (a) ubiquitin-histone con- 
jugates were enriched by more than twofold in interphase 
cells  (2.4-fold  by  SDS  PAGE  and  2.1-fold  by  acid-urea 
PAGE); (b) mitotic ceils contained a unique 26,000-mol-wt 
ubiquitin conjugate; and (c) mitotic cells contained slightly 
more (1.3-fold) free ubiquitin. No more than half of the re- 
sidual ubiquitin-histone conjugates observed in mitotic cells 
could be attributed to contamination from interphase cells 
since the mitotic index was >85 % for all preparations of mi- 
totic cells. 
Characterization  of the Three Ubiquitin Pools 
The Free Pool. The free ubiquitin pool might consist of ac- 
tive but unconjugated molecules or of damaged molecules 
incapable of conjugation. The presence of inactive ubiquitin 
is a  distinct possibility since the COOH-terminal glycine 
residues can be easily removed from this protein by trypsin 
(58), or an unidentified protease possibly of  lysosomal origin 
(22).  To estimate the proportion of injected ubiquitin mole- 
cules capable of conjugation, HeLa cells injected with BH- 
ubiquitin were treated with phenylhydrazine to denature the 
co-injected hemoglobin. Confirming earlier results (8), we 
found that >85 % of the injected ubiquitin appeared as con- 
jugates, most with molecular weights expected for globin- 
ubiquitin adducts (Fig. 5). These results indicate that at least 
Table 1. Localization of Ubiquitin and Ubiquitin Conjugates 
Distribution  of ubiquitin and 
ubiquitin conjugates 
Fractionation  Free 
procedure  Location  Conjugates  ubiquitin  Total 
%  %  % 
Homogenization in  Postnuclear 
0.25  M  sucrose  supernate  18  37  55 
Nuclear pellet  29*  16  45 
Total  47  53  100 
Extraction in 
0.5% Triton X-100  Soluble  29  45  74 
Insoluble  21 ~  5  26 
Total  50  50  100 
Direct solubilization 
in SDS 
(whole cells)  Total  51 §  49  100 
Lanes from the gel in Fig. 5 were cut into 5-mm segments, and gamma spec- 
troscopy  was  used  to  determine  the  fraction  of free  and  conjugated  ~2sI- 
ubiquitin. 
* Of these conjugates, 22 % were historic conjugates. This represents 6.5 % of 
the total ubiquitin and  suggests isopeptidase activity  in sucrose  fractionated 
nuclei since cells solubilized in Triton X-100 or SDS had a higher proportion 
of histone conjugates (see below). 
~: Of these conjugates, 47%  were histone conjugates; this represents 9.9%  of 
the total ubiquitin. 
§ Of these conjugates, 22% were histone conjugates; this represents  l 1.1% of 
the total ubiquitin. 
85 % of the injected ubiquitin was active. In the following pa- 
per (6), we report even greater conversion of ubiquitin to 
HMW forms after heat-shock. Thus, the substantial size of 
the free pool in HeLa cells maintained under normal growth 
conditions cannot be attributed to the presence of inactive 
ubiquitin molecules. 
To determine what fraction of the free ubiquitin pool may 
have arisen by release from conjugates during SDS PAGE 
analysis (e.g., ubiquitin in thiol ester linkage to activating en- 
zymes [9, 28, 46]), proteins from injected cells were elec- 
trophoresed at low temperature under nonreducing condi- 
tions. Fig. 6 shows that additional conjugates were present 
in samples analyzed in this manner. The most prominent of 
these had a molecular weight of 110,000, the size expected for 
a  ubiquitin-E1  thiol  conjugate  (9).  Unique  conjugates at 
30,000  and 38,000  were also observed under nonreducing 
conditions, and they may represent ubiquitin-E2  thiol ad- 
ducts. The existence of other ubiquitin-E2  thiol conjugates 
is  suggested by a  twofold increase in radioactivity in the 
20,000-24,000-mol-wt region of the gel under nonreducing 
conditions.  Thus,  using mild preparative procedures,  the 
free pool decreased by one-third suggesting that as much as 
15 % of the injected ubiquitin associates with HeLa proteins 
in complexes labile to reduction and/or boiling. Over 80 % 
of these labile conjugates have molecular weights consistent 
with those expected for complexes between ubiquitin and the 
EL or E2 components of the activation pathway (46). 
Histone Conjugates. The most prominent ubiquitin con- 
jugates in HeLa cells, a doublet with a molecular weight of 
'~22,000 on SDS PAGE (Fig. 1 a), are ubiquitin-histone ad- 
ducts by the following criteria: (a) they appear only in nu- 
clear fractions (Fig.  4) and form more slowly than HMW 
conjugates (Fig.  1 c); (b) their molecular weights are consis- 
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migrate with a  22,000-mol-wt molecule formed from 1251- 
H2A in rabbit reticulocyte lysates;  and  (d) they decrease 
significantly at mitosis (Fig. 4 B). As already noted, ubiqui- 
tin-histone conjugates form more slowly than HMW con- 
jugates (Fig. 1 c). This is expected since in vivo studies show 
that uH2A becomes labeled by exchange of ubiquitin with an 
apparent half-life of 90 rain (52). 
HMW Conjugate Pool Of the three intracellular ubiqui- 
tin pools, the HMW conjugate pool is the most diverse, con- 
raining conjugates that vary on SDS PAGE from 25,000 to 
greater than 250,000 (see Fig. 4). These conjugates did not 
dissociate  from  even  larger  soluble  complexes  since  the 
majority of the injected ubiquitin sediments on sucrose den- 
sity gradients as molecules with weights less than 250,000 
(Fig.  7). 
The physiological significance of the HMW ubiquitin con- 
jugates  is  not clear.  Denatured hemoglobin and abnormal 
proteins form ubiquitin conjugates and are rapidly degraded 
(8, 27). If the major role of ubiquitin is to mark proteins for 
proteolysis, then the sizable fraction of newly synthesized 
proteins that are rapidly degraded (47) might be expected 
Figure 6. Analysis of ubiqui- 
tin  conjugates  under  nonre- 
ducing conditions. HeLa cells 
were  injected  with  t25I-ubiq- 
uitin and 6 h later cells were 
either dissolved in SDS sample 
buffer containing 2-mercapto- 
ethanol and boiled (Reducing) 
or extracted with Triton X-100 
buffer containing DNase I and 
then dissolved in SDS sample 
buffer  lacking  2-mercapto- 
ethanol (Non-reducing). SDS 
PAGE analysis was conducted 
at 4°C to preserve thiol esters. 
Each  lane  contained  15,000 
cpm and autoradiographic ex- 
posure was for 3 d. After au- 
toradiography,  the  gel  was 
sliced into 5-mm pieces, and 
the distribution of radiolabel 
was determined  by direct  count- 
ing. Prominent bands appar- 
ent under nonreducing condi- 
tions are denoted by arrows. 
~gure 5. Ubiquitin-globin  con- 
jugates  in HeLa cells. HeLa 
cells were injected with  ~25I- 
ubiquitin, and at 12 h post-injec- 
tion phenylhydrazine was add- 
ed to a final concentration of 
350 laM. 90 min later, treated 
and  control  cells  were  dis- 
solved in SDS sample buffer, 
and their intracellular proteins 
were analyzed by SDS PAGE 
followed by autoradiography. 
Quantitation by gel slicing re- 
vealed that only 13 % of the in- 
jected ubiquitin  remained  in 
the free pool after phenylhy- 
drazine administration. Ubiq- 
uitin conjugates with molecu- 
lar weights corresponding to 
the  addition of one,  two, or 
four  ubiquitin molecules  to 
globin were prominent in cells 
exposed  to  phenylhydrazine 
and are marked by arrows. 
to form conjugates with ubiquitin.  This hypothesis, which 
predicts a  decline in  HMW conjugates upon inhibition of 
protein synthesis, was tested by incubating injected cells in 
media containing cycloheximide and comparing conjugate 
pools to those of control cells (Fig. 8). Even 8 h after block- 
ing protein synthesis, none of the HMW conjugate bands dis- 
appeared. The HMW pool did, however, decrease by 20% 
in cyclobeximide-treated cells, the decrease occurring prin- 
cipally  in  conjugates  with  molecular weights  larger  than 
66,000. These results suggest that most HMW conjugates are 
not proteolytic intermediates of newly synthesized, rapidly 
degraded proteins. 
Discussion 
In this study, we have presented data on the distribution and 
metabolism of injected ubiquitin. Implicit in our analysis is 
the assumption  that the behavior of the injected molecule 
mirrors that of endogenous ubiquitin. A number of observa- 
tions  support  this  supposition.  Injected ubiquitin  formed 
conjugates to HeLa proteins including H2A and H2B, and 
nearly all of the injected molecules were capable of forming 
such conjugates (Fig. 5). Also, the data in Fig. 3 show that 
injected  ubiquitin  was  degraded  at  a  rate  similar  to  that 
reported for the endogenous molecule (60).  A  number of 
other studies also suggest that injected, labeled proteins can 
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Figure 7, Sedimentation analysis of injected ubiquitin. HeLa cells 
were injected with ~25I-ubiquitin and extracted 8 h later with buffer 
containing Triton X-100. The soluble fraction was diluted 4:1 and 
N-ethylmaleimide was added to a final concentration of 5 mM to 
inhibit isopeptidases.  A portion  of this extract (300 Ixl) was then 
centrifuged on a 5-ml, 5-25% sucrose gradient, for 15 h at 29,000 g 
in a Beckman SW39 rotor. The gradient was collected from the bot- 
tom in 15 equal fractions, and the radioactivity in each fraction was 
determined.  Molecular  weight  markers  were  catalase  (CAT), 
250,000; yeast alcohol dehydrogenase (ADH), 150,000; hemoglo- 
bin  (Hb),  64,000;  and  lysozyme,  14,000. Their positions  were 
identified as described  (30). 
serve as legitimate probes of the behavior of  endogenous pro- 
teins. Examples include the accumulation of injected muscle 
and cytoskeletal proteins in the appropriate subceUular sub- 
structures  (17,  33),  the  nuclear  accumulation  of  chro- 
mosomal proteins HMG1  and HMG2 after RBC-mediated 
microinjection (49),  and the observation that half-lives for 
many injected proteins closely approximate those obtained 
by in vivo labeling (39,  50). 
Even if the injected ubiquitin molecules behave normally, 
they could shift the apparent distribution of ubiquitin among 
conjugates if they significantly altered the size of the endoge- 
nous pool. About 105 labeled ubiquitin molecules are trans- 
ferred from each loaded RBC, and the following calculation 
shows this to be <0.1% of the endogenous pool. The numbers 
of ubiquitin and H2A molecules are roughly equal since 10% 
of the intracellular ubiquitin is conjugated to H2A and vice 
versa (55). Based on a DNA content of 17 pg per cell (36), 
we estimate that a  HeLa cell contains  1.5  x  108 copies of 
H2A, hence an equivalent number of ubiquitin molecules. 
This value is similar to estimates by Haas and Bright (21) 
based  on  immunological  methods  that  nucleated  cells 
contain  between  0.8  and  1.8  x  108  ubiquitin  molecules. 
Moreover, according to Haas and Bright, an RBC contains 
'~3  ×  106  ubiquitin  molecules  (21).  Therefore,  the  total 
contribution of labeled and unlabeled ubiquitin from RBC- 
mediated injection is <2 % of the amount already present in 
a  HeLa cell. 
Knowing the number of ubiquitin molecules per cell, we 
can estimate minimal levels of various "activating" enzymes 
if we assume that the bands seen only under  nonreducing 
conditions are thiol ester adducts of ubiquitin to components 
of the conjugation pathway. About 3 % of the total ubiquitin 
Figure 8. Fate of  ubiquitin conjugates after inhibition of  protein syn- 
thesis. HeLa cells were injected with 12SI-ubiquitin, and 5 h later 
medium containing 1(30 I.tM  cycloheximide was added. SDS PAGE 
analyses of cellular proteins were performed at 2 and 8 h after addi- 
tion  of cycloheximide  (Cyclo) and  on  cells  in  normal  growth 
medium  (Control). After SDS PAGE, autoradiography  was per- 
formed with the gels being exposed for 2.5 d. Each lane contained 
10,000 cpm. 
migrates as a putative ubiquitin-El  complex (Fig. 6) corre- 
sponding to 4  x  106 copies of E1 per cell. Some of the in- 
dividual  E2s appear to be less abundant  since the putative 
thiol ester conjugates migrating at 30,000 and 38,000 com- 
prise only 1.3 % and 0.3 %, respectively, of the total ubiquitin 
injected. Other ubiquitin-E: complexes, which might be ex- 
pected at 21,000,  25,000,  and 28,000  (46)  were either not 
present or were masked by co-migration with histone con- 
jugates. However, an additional 10% of the injected ubiquitin 
migrated  between  20,000  and  24,000  under  nonreducing 
conditions, so smaller E2 carrier proteins may be even more 
abundant than El. 
Our results indicate that under normal culture conditions, 
40 % of the ubiquitin molecules in HeLa cells are present as 
HMW conjugates,  10%  as histone conjugates,  15%  as ad- 
ducts labile to boiling and reduction, and the remaining 35 % 
as  free  ubiquitin.  The  latter  value  is  in  agreement  with 
findings of Haas and Bright (21) who reported that 40 and 
26%  of the  ubiquitin  is  unconjugated  in  human  IMR-90 
fibroblasts and monkey CV-1 cells,  respectively. In partial 
agreement with reports that uH2A and uH2B are absent in 
metaphase cells (37, 41, 60),  we observed a clear reduction 
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ubiquitin-histone conjugates were present that could not be 
attributed to contaminating  interphase cells.  Perhaps some 
colcemid-arrested  mitotic  cells  had partially  entered  ana- 
phase and re-ubiquitinated H2A. It is also possible that BH- 
ubiquitin is more resistant to isopeptidase activity (1, 38) and 
radioiodinated ubiquitin molecules  remain attached to his- 
tones at metaphase when native ubiquitin is stripped. Finally, 
in  contrast  to  Chinese  hamster  ovary  cells  or Physarum, 
HeLa cells may resemble rat hepatoma cells by retaining re- 
sidual histone conjugates at metaphase (48). 
Besides providing information on the partitioning of ubi- 
quitin  at  equilibrium,  microinjection  reveals  dynamic 
aspects of ubiquitin metabolism.  HMW conjugates must be 
generated very rapidly because they are fully labeled within 
the 30 min required for fusion (see Fig.  1 a). The slower for- 
mation of H2A conjugates from injected ubiquitin (Fig.  1 c) 
agrees with in vivo labeling experiments showing that equil- 
ibration of newly synthesized ubiquitin with uH2A takes 1-2 
h  (52).  The  pattern  of ubiquitin  conjugates  remained  un- 
changed during the 30-h period after injection.  This indi- 
cates that stable ubiquitin conjugates are rare  or absent in 
HeLa cells since the concentration of such conjugates would 
have been expected to increase with time. The apparent ab- 
sence of "stable" conjugates and the rapid redistribution of 
ubiquitin to denatured globin (Fig.  5) implies that most, if 
not all, ubiquitin molecules are in dynamic equilibrium with 
HeLa proteins. 
Except for uH2A and uH2B, the identity of ubiquitin con- 
jugates observed by SDS PAGE is unknown.  Only 20%  of 
the HMW conjugate pool consists of potential intermediates 
in the degradation of proteins with short half-lives.  The re- 
maining conjugates may be stable proteins marked for de- 
struction or alternatively,  ubiquitin conjugation may  serve 
other functions.  Several prominent conjugates, always seen 
between 50,000 and 130,000 and at 30,000 (cf.  Fig. 4 B and 
8), could be proteins whose activity is regulated by ubiqui- 
tin.  Munro and Pelham  (42) propose that a putative heat- 
shock transcription factor might be inactivated by ubiquitina- 
tion  and  that  ubiquitin  removal  activates  this  factor  after 
heat-shock. The rapid depletion of free ubiquitin upon heat- 
shock is consistent with this proposal (see the following pa- 
per [6]). Finally, the unique 26,000-mol-wt mitotic conjugate 
(Fig. 4 B) raises further questions regarding the role of ubiq- 
uitin marking. If this conjugate and a similar size conjugate 
observed in permeabilized mitotic and interphase rat hepa- 
toma cells (48) are the same, then cell cycle-specific conjuga- 
tion of ubiquitin to certain proteins may be sensitive to condi- 
tions that change after cellular permeabilization.  The 26,000 
conjugate formed at mitosis in vivo could be a proteolytic in- 
termediate  of an  18,000-mol-wt  protein  degraded  only  at 
metaphase, or the conjugate might reflect regulation through 
ubiquitin marking.  Inability  to form a similar conjugate in 
ts85 cells could explain why they arrest in G2 at nonpermis- 
sive temperatures  (15). 
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